Abstract The circadian clock in the mammalian suprachiasmatic nuclei (SCN) expresses 24-h rhythms when isolated in vitro. Numerous studies have demonstrated that recordings of SCN single-unit neuronal activity (SUA), when expressed as a population rhythm, can be used to reliably estimate SCN circadian clock phase in vitro. The main disadvantage of this technique is its laborious nature. Thus, the present experiments were designed to investigate whether in vitro multi-unit neuronal activity (MUA) recordings from the SCN could reliably substitute for SUA recordings. The results show that an MUA rhythm can be recorded from rat SCN for 3 days in vitro but that this rhythm is extremely variable; times of peak MUA in control experiments vary by 7 to 9 h each day. They also show that several serotonergic agents previously shown to consistently advance the SUA rhythm 2 to 3 h when applied during the day induce apparent advances in the MUA rhythm in some experiments; in other cases, however, there appears to be a delay or no change in the phase of the rhythm. Thus, the mean change in time of peak seen after these treatments was an advance of about 1 h. Finally, the results show that glutamate and optic chiasm stimulation applied during early subjective night can induce apparent delays in the MUA rhythm. The results of these experiments were less variable, so that the overall effect was a delay in peak MUA of 2.5 to 3.5 h. Nevertheless, these experiments still exhibited more variability than that generally seen in SUA experiments. Taken together, these results indicate that MUA recordings of the SCN exhibit significantly more variability than do SUA recordings. The extent of this variability leads to the conclusion that, using the techniques and equipment outlined here, MUA recordings are not an adequate substitute for SUA recordings when trying to estimate the phase of the SCN circadian clock.
INTRODUCTION
The mammalian suprachiasmatic nuclei (SCN) contain a circadian clock that controls most daily rhythms of behavior and physiology (Turek, 1985) . Support for this comes in part from studies showing that the SCN continue to produce a variety of 24-h rhythms when isolated in vitro (Shibata and Moore, 1988; Miller, 1993; Inouye and Shibata, 1994) . The SCN clock, when isolated in a brain slice preparation, also retains its ability to be reset, or phase shifted, by a variety of treatments (Gillette et al., 1995; Miller, 1993) . For these and other reasons, this preparation has proved to be extremely useful for studying the SCN circadian pacemaker.
In vitro phase-shifting studies generally have used extracellular, single-unit neuronal activity (SUA) recordings to determine the phase of the SCN clock. For these experiments, the spontaneous firing rates of many individual cells are monitored for brief periods (e.g., 5 min) over the course of a 10-to 72-h experiment. The firing rates of these individual cells subsequently are grouped into 1-to 2-h averages to obtain a measure of population neuronal activity over time. This averaged SUA exhibits a circadian rhythm in vitro that has been shown to accurately reflect the phase of the underlying clock (Green and Gillette, 1982; Prosser and Gillette, 1989) . More specifically, the time of peak SUA has been used as a phase marker so that shifts in peak SUA can be used to estimate shifts in circadian clock phase Prosser et al., 1993; Ding et al., 1994; Shibata et al., 1994) . Although this procedure has proved to be quite reliable, it also is extremely labor intensive. Therefore, it seemed worthwhile to investigate whether a more automated method of recording in vitro SCN neuronal activity for extended periods (e.g., 2-3 days) could be developed.
A recent study elegantly showed that it was possible to record a clear rhythm in multi-unit neuronal activity (MUA) from the SCN during the first 24 h in vitro using a single-wire electrode (Bouskila and Dudek, 1993) . This MUA rhythm closely matched the population SUA rhythm recorded in vitro in that MUA increased during early subjective day, peaked near midday, and was low during the subsequent subjective night. Furthermore, as with the SUA rhythm, Bouskila and Dudek (1993) reported little variation in the times of peak MUA both between experiments and between different regions of a single SCN. More recently, Meijer et al. (1997) reported a study examining in vivo versus in vitro MUA recordings from the SCN in which their in vitro recordings used this same technique. Again, these recordings generally lasted for only 1 circadian cycle, during which time they exhibited a circadian pattern of activity. Finally, another recent study (Tcheng and Gillette, 1996) reported in vitro MUA recordings from the SCN using slightly different techniques. In this case, brain slices were maintained in a modified Haas-style slice chamber and recordings were made using carbon fiber electrodes. Although the study focused primarily on characterizing the recordings obtained during the first 6 h after slice preparation, it includes a single experiment in which MUA was successfully recorded for 3 days. Together, these studies raise the possibility that routine, long-term recordings of MUA from the SCN are possible.
This study, therefore, was designed to determine (1) whether MUA recordings could be extended into the 2nd and 3rd days in vitro, (2) whether the MUA rhythm seen on subsequent days in vitro continued to match the population SUA rhythm seen in previous experiments, and (3) whether pharmacological agents previously found to phase shift the population SUA rhythm would induce similar shifts in the MUA rhythm in vitro.
In the intact animal, the SCN circadian clock receives neuronal input primarily from three sources: a direct retinal input that primarily contains glutamate (Moore and Lenn, 1972; Castel et al., 1993) , thalamic input from the retinorecipient intergeniculate leaflet using neuropeptide Y and γ-aminobutyric acid (Card and Moore, 1989; Morin et al., 1992; Harrington et al., 1987; Moore and Speh, 1993) , and serotonergic input from the midbrain raphe nuclei (Moore et al., 1978) . The experiments in this study investigated the effects of two of these neurotransmitter systems on the in vitro MUA recordings. The serotonergic input was investigated using serotonin, a nonselective serotonergic agonist (quipazine), and a serotonin agonist selective for the 5-HT 1A and 5-HT 7 receptors (8-OH-DPAT). Each of these compounds has been found to consistently advance the SCN clock when applied during the subjective day in vitro (Shibata et al., 1992; Prosser et al., 1993; Medanic and Gillette, 1992) . The glutamate input from the retina was investigated using glutamate and electrical stimulation of the optic chiasm. Both of these treatments have been found to delay the SCN clock when applied during early subjective night in vitro Ding et al., 1994; Shibata and Moore, 1993) . The advantages of investigating these two afferent systems are that (1) different aspects of circadian physiology could be explored and (2) they would test the ability of two modes of stimudissection of two distinct actions of melatonin on the suprachiasmatic circadian clock. Neuron 19:91-102.) Using techniques similar to those used here, the authors state that the melatonin-induced phase shifts seen in their SUA recordings were not apparent in their MUA recordings. Their results thus appear to be consistent with the results reported here. lation (chemical and electrical) to affect the rhythm of MUA.
MATERIALS AND METHODS

Brain Slice Preparation
Coronal brain slices (500 ) containing the SCN were prepared during the daytime from adult male Sprague-Dawley rats housed in a light:dark 12:12 cycle, as reported previously Prosser et al., 1993) . In a few experiments, brain slices were prepared from adult male Wistar rats housed under the same conditions. Slices were maintained at the interface of a Hatton-style brain slice chamber (Hatton et al., 1980) , where they were perfused continuously with warm (37ºC), oxygenated (95% O 2 /5% CO 2 ), glucose/bicarbonate-supplemented Earle's balanced salt solution (Sigma), pH 7.4 to 7.5. The space beneath the filter paper supporting the slices was filled with glass boiling beads to prevent the filter paper from sagging during the experiment. In addition, two thin strips of filter paper were placed on top of each brain slice, leaving the SCN exposed. Both of these modifications were aimed at increasing the stability of the slices in the recording chamber and were used in both SUA and MUA experiments.
Multi-Unit Recordings and Data Analysis
MUA was recorded using a single 76-µ diameter, blunt-cut, teflon-coated metal electrode (90% platium and 10% iridium) (Bouskila and Dudek, 1993) . The electrode was first placed on the surface of the optic chiasm ventrolateral to the SCN to determine the level of background electrical noise. Then it was moved to the SCN and lowered 50-100 µ into the slice to increase the stability of the recording. A threshold for counting electrical events (neuronal activity) was then set to at least twice the level of background noise and often as high as 3 to 4 times background noise. Neuronal activity, expressed as the number of threshold crossings per second, was monitored for 5 min 4 times per hour using a DataWave data collection and analysis system. Recording usually began within 1 hour of slice preparation and continued for 2 to 3 days. The activity detection threshold was adjusted when necessary during the course of an experiment to maintain adequate sampling of neuronal activity. In some experiments, the electrode had to be repositioned due to a decrease in neuronal activity counts. If this occurred close to the eventual peak in MUA for that day, then the data were discarded. This is because repositioning the electrode altered the pattern of electrical activity during the subsequent 2 to 3 hours, making the data immediately prior to and following electrode repositioning unreliable. Data also were discarded when electrical activity dropped off precipitously immediately after reaching a peak. This is because the dropoff could reflect either poor health of the slice or instability of the recording.
At the end of each experiment, the data were imported into a graphics/statistics software program to plot MUA and calculate polynomial regressions to determine the time of peak, rounded to the nearest quarter hour, for each day in vitro. Phase shifts were calculated as the difference in time of peak of treated slices versus that of untreated slices.
Single-Unit Recordings and Data Analysis
SUA recordings were obtained using methods described previously (Prosser et al., 1993) . Briefly, the spontaneous activity of single SCN neurons was recorded using glass capillary microelectrodes filled with 3M NaCl. Each neuron was recorded for 5 min, and the data were stored for later determination of firing rate using a DataWave system. These firing rates were then used to calculate 2-h running averages, lagged by 1 h, to obtain a measure of population neuronal activity. As in previous studies (Prosser et al., 1993) , the time of peak SUA was defined as the time of symmetrically highest activity estimated to the nearest quarter hour. Thus, if the two highest 2-h means were equivalent, then the time of peak activity would be midway between them. This method of estimating time of peak has proved to be highly reliable (Prosser et al., 1993; Prosser and Gillette, 1989; Medanic and Gillette, 1992; Ding et al., 1994) .
Experimental Treatments
All drugs were applied during the 1st day in vitro by stopping perfusion and replacing for 1 h the bathing medium in the slice chamber with medium containing the test compound. At the end of the hour, the treated medium was exchanged with normal medium, and perfusion was resumed. Recordings were stopped at the beginning of the treatment and were resumed at the end of treatment because the electrode had to be removed from the slices to exchange the perfusion medium. In some cases, recordings were obtained during the treatment period. Chemicals used in the study were quipazine maleate (Miles Laboratories and Research Biochemicals), L-glutamic acid (Sigma), (±)-8-hydroxy-dipropylaminotetralin HBr (8-OH-DPAT), and serotonin (5-HT) (Research Biochemicals). Serotonergic compounds were applied at Zeitgeber Time (ZT) 6 to 7 (where ZT 0 = lights on in the donor colony), and glutamate was applied at ZT 15 to 16.
For optic chiasm stimulation, the MUA recording was stopped and a bipolar tungsten electrode, insulated except for the tips, was positioned in the optic chiasm ventrolateral to the SCN. Voltage (10 Hz, 10 V, 3 msec) was applied three times for 10 min, with each period of stimulation separated by 10 min. At the end of the third stimulation, MUA recording was resumed. This treatment was applied from ZT 14 to 15.
RESULTS
Control Experiments
Clear rhythms in MUA were apparent for at least 2 days in vitro and occasionally for 3 days. Figure 1 shows two 3-day control experiments. In Fig. 1A , the times of peak MUA occurred at ZTs 7.0, 7.0, and 7.25 on Days 1, 2, and 3, respectively. Thus, in this experiment, the times of peak MUA were fairly consistent across the 3 days in vitro, and the rhythm closely followed the pattern seen previously in SUA experiments. In the experiment shown in Fig. 1B , however, activity exhibited multiple peaks on Day 1 in vitro and then peaked near ZT 11.0 on Days 2 and 3, with several smaller peaks apparent in the record. Thus, this experiment exhibited a much different pattern of MUA. In some instances, two experiments were run simultaneously using slices prepared at the same time and much of the same electronic hardware. The pattern of MUA recorded in these experiments did not necessarily exhibit parallel changes (e.g., Fig. 2 ), indicating that the activity being recorded was not simply an artifact of the recording environment. Overall, a total of 59 control experiments were conducted in which reliable recordings were obtained on Days 1, 2, and/or 3 in vitro. The results of these experiments, in terms of the mean times of peak ± SD for each day in vitro, are summarized in Table 1 .
To investigate whether the strain of rat used in these experiments could be the source of the variability seen in the MUA experiments, a few control MUA experiments were conducted using Wistar rats. The results of these experiments are as follows: mean time of peak for Day 2 in vitro = ZT 7.44 ± 2.59, n = 8, range 4.25-11.5. Although the mean time of peak differs slightly from that obtained in experiments using Sprague-Dawley rats, the degree of variability is quite comparable.
SUA recordings also exhibited clear rhythms. In all cases, the pattern of these rhythms was quite similar to what has been seen previously; that is, activity peaked on Day 2 in vitro near mid-subjective day. The results of the SUA experiments, together with those from previous SUA experiments Prosser et al., 1990) , are summarized in Table 1 . It is clear that although SUA and MUA recordings resulted in similar mean times of peak, the MUA recordings exhibited a great deal more variability than did the SUA recordings.
Phase-Shifting Experiments: Serotonin Compounds
All three serotonergic compounds, when applied to the slices at ZT 6 to 7, advanced the MUA rhythm in some experiments. For example, Fig. 3A shows an experiment in which the time of peak was advanced after 8-OH-DPAT treatment. However, other experiments showed no effect (Fig. 3B) or a delayed peak after treatment with a serotonergic compound. The results of all the experiments involving these compounds are summarized in Table 2 . Overall, each treatment induced a mean advance of about 1 h, with the results of individual experiments being extremely variable. None of them induced a significant advance in the time of peak MUA when analyzed separately, but when the results of all the experiments involving serotonergic applications are combined, the resulting mean time of peak (ZT 5.19 ± 0.86, n = 39) was significantly different from that of controls (p < .05). The overall distribution of the times of peak MUA on Day 2 in vitro for control and treated slices is plotted in Fig. 4 . A clear difference is apparent in the distribution of peak times for the different groups despite their large degree of overlap. For example, although the times of peak seen after serotonergic stimulation often occurred near or after the mean times of peak of controls, a large fraction of them peaked at phases in advance of the range of times exhibited by control experiments.
To aid in the comparison of MUA experiments with SUA experiments, the results of previous SUA experiments using these compounds are included in Table 2 . The increased variability of the MUA results is evident in both the larger standard deviations and the larger ranges in times of peak activity.
Phase-Shifting Experiments: Glutamate and Optic Chiasm Stimulation
Delays in the time of peak MUA occurred after both glutamate and optic chiasm stimulation in most experiments, but again, these treatments did not always have the expected effect. For example, both apparent delays (Fig. 5A) and advances (Fig. 5B) were observed after optic chiasm stimulation at ZT 14. As is evident from the distribution of times of peak (Fig. 4) , once again there was a large degree of interexperimental variability, resulting in a sizable amount of overlap Prosser et al. (1993) . NOTE: 8-OH-DPAT = (±)-8-hydroxy-dipropylaminotetralin HBr. *p < .01 compared to time of peak multi-unit activity in control slices. between the times of peak in control experiments and those in experiments receiving these treatments. Nevertheless, unlike the results with serotonergic applications, the mean time of peak MUA was significantly delayed by both glutamate and optic chiasm stimulation treatments when analyzed separately (Table 2) .
DISCUSSION
These results demonstrate that a circadian-like rhythm of MUA can be recorded from rat SCN for 3 days in vitro and that the mean phase of this rhythm is similar to that obtained in SUA experiments. Thus, this study confirms and extends the previous studies showing 24-h rhythms in MUA recorded from the SCN in vitro (Bouskila and Dudek, 1993; Tcheng and Gillette, 1996; Meijer et al., 1997) . However, these experiments also clearly illustrate that the rhythm of MUA recorded using these techniques is extremely variable, with the time of peak activity ranging across 7 to 9 h on each day in vitro.
These results further demonstrate that, at least in some experiments, a variety of in vitro treatments appear to advance or delay the time of peak MUA in a manner consistent with previous SUA experiments (Prosser et al., 1990 (Prosser et al., , 1993 Harrington et al., 1993; Ding et al., 1994; Shibata and Moore, 1993; Shibata et al., 1994; Shibata et al., 1992; Medanic and Gillette, 1992) . However, there are many experiments in which these same treatments did not result in the expected changes in time of peak neuronal activity. The distribution of times of peak obtained from control and treated slices in all cases overlapped considerably. Thus, many of the apparent phase shifts seen after these treatments could simply reflect the inherent variability of the MUA recordings.
The source(s) of the variability seen in these MUA recordings is not clear. Several different possibilities were explored during the course of these investigations. The first was the possibility that the drugs used in these experiments were compromised. This does not appear to be the problem for the following reasons. First, all drugs were prepared fresh for each experiment. Second, in the case of quipazine, two different sources of the compound were used, and both produced variable results (data not shown). Third, 8-OH-DPAT from at least three different lots were used over the course of 2 1 ⁄2 years with no differences seen among them (data not shown). Fourth, control experiments and optic chiasm stimulation experiments both exhibited the same degree of variability as experiments involving drug treatments. Therefore, the drugs used in these experiments do not appear to be the source of the variability.
The second possibility investigated was that the strain of rat used in these experiments (SpragueDawley) has more variable in vitro rhythms than did the strains used in previous SUA studies (Wistar: Prosser et al., 1990 Prosser et al., , 1993 Shibata et al., 1992 Shibata et al., , 1994 Shibata and Moore, 1993; inbred Long-Evans: Prosser and Gillette, 1989; Ding et al., 1994; Medanic and Gillette, 1992) . The control MUA experiments using Wistar rats, however, displayed a degree of variability similar to that seen with the Sprague-Dawley rats. Thus, the strain of rats does not appear to be the source of the variability.
A third possibility investigated was that some factor associated with the recording system, brain slice chamber, slice preparation and maintenance, and/or animal housing conditions could be causing the increased variability. Thus, a number of control SUA experiments were run concurrent with the MUA experiments using Sprague-Dawley rats housed alongside rats used in MUA experiments, maintaining the brain slices in the same slice chambers and using the same recording equipment (other than the recording electrode itself). These experiments exhibited the typical low variability reported previously for SUA experiments. Therefore, these results appear to eliminate a large number of laboratory, equipment, and animal housing factors as being the cause of the variability seen in MUA recordings.
One difference between MUA and SUA recordings is that SUA recordings sample the firing rates of cells throughout the SCN, whereas MUA recordings (assuming the electrode was not moved) probably sample from a more localized portion of the SCN (e.g., Tcheng and Gillette, 1996) . It is unlikely, however, that this is the source of the variability seen in the MUA. Bouskila and Dudek (1993) recorded from separate parts of the SCN simultaneously and found no difference in the phase of the MUA rhythms during the first 24 h in vitro. Likewise, Tcheng et al. (1989) found that when the firing rates of cells recorded from the ventrolateral SCN are analyzed separately from those recorded from the dorsomedial SCN, the times of peak SUA on Day 2 in vitro are coincident. These data suggest that regionally restricted recordings from the SCN should not display more variability than do recordings obtained from throughout the SCN. However, this issue clearly warrants further investigation.
A likely cause of much of the variability seen in the MUA recordings is the gradual changes in the slice/electrode interface that occur to differing degrees in individual MUA experiments. Movement of the electrode within the slice and changes in the level of the perfusion medium surrounding the slice clearly affect the MUA recordings, and changes in these factors certainly occur in some experiments over the course of the 2 to 3 days in vitro. For example, the brain slices sometimes change their shape while they are maintained in vitro, sometimes by flattening out and less often by an expansion of the third ventricle. These shape changes tend to occur very slowly and inevitably will result in movement of the tissue at the tip of the electrode. Furthermore, these types of changes are difficult to eliminate. Although lowering the electrode into the brain slice preparation, supporting the filter paper under the slices with glass beads, and placing strips of filter paper on the surface of the slices all significantly increased the stability of the MUA recordings, further improvements along these lines clearly are needed.
Several groups recently have explored the usefulness of in vitro MUA recordings from the SCN. The first group (Bouskila and Dudek, 1993) focused on MUA during the 1st day in vitro and found a consistent pattern of MUA with a peak near mid-subjective day. More recently, Tcheng and Gillette (1996) published a study on in vitro MUA recordings from the SCN using a carbon fiber bundle microelectrode and a modifed Haas (solid surface) brain slice chamber. Although their study focused primarily on the recordings obtained during the first few hours in vitro, they showed a single 3-day recording of MUA. However, the exact time of peak MUA was not given, and they did not discuss how variable their MUA recordings were. Therefore, it is not possible to determine whether differences in the recording electrode and/or brain slice chamber alter the degree of variability exhibited by the MUA recordings. Another recent study (Meijer et al., 1997) investigated the variability of in vivo and in vitro MUA recordings of the SCN. The focus of this study was the variability among individual 10-sec samples of neuronal activity throughout the first 24 h of recording, and they found in vitro MUA recordings to exhibit less variability than in vivo MUA recordings. However, they did not discuss variability in the times of peak MUA, nor did they extend their recordings beyond the first cycle of activity in vitro. Finally, a fourth group (Gribkoff et al., 1995) published preliminary results of a study using in vitro MUA recordings to follow the rate of in vivo phase shifting in response to a change in the light:dark cycle. Again, the extent of variability in their MUA recordings, and any differences in their techniques and equipment from those used here, cannot be determined from the information included in their report. In summary, it is difficult to determine whether our results with MUA recordings differ significantly from those of other groups.
In conclusion, under the conditions used in these experiments, there appears to be too much variability in the pattern of MUA for it to be useful for estimating SCN circadian clock phase. Therefore, unless this variability can be eliminated, MUA recordings of SCN neuronal activity do not seem to be an adequate substitute for SUA recordings when investigating in vitro phase shifting.
